Medicare Enrolled
Dr. Brian Bradley, MD
Urology Physician · San Angelo, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bradley from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bradley?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bradley
Dr. Brian Bradley is an urology physician in San Angelo, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Bradley performed 6,421 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Bradley received a total of $3,467 from 33 pharmaceutical and/or device companies across 128 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bradley is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 17% volume in TX
$3,467 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗6,421
Medicare services
Top 17% in TX for urology physician
Not available
Unique patients (not deduplicated)
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,980 | $18 | $33 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
808 | $4 | $24 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
668 | $8 | $8 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
506 | $86 | $216 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
488 | $65 | $150 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
386 | $502 | $1,046 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
327 | $172 | $440 |
| Hormone pellet insertion under the skin A small hormone pellet is placed just beneath the skin to release medication slowly over time. |
307 | $70 | $278 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
197 | $112 | $320 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 168 | $134 | $418 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
155 | $7 | $55 |
| Lower leg neurostimulator electrode insertion A procedure to place an electrode in the lower leg for neurostimulation therapy. |
120 | $86 | $371 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
37 | $11 | $50 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
35 | $86 | $446 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
35 | $21 | $215 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
34 | $0 | $10 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
28 | $26 | $95 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
23 | $246 | $996 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
22 | $56 | $209 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
20 | $73 | $209 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
18 | $100 | $268 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
17 | $247 | $874 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
15 | $567 | $1,958 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
14 | $291 | $1,273 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
13 | $96 | $1,532 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.7% high complexity
36.2% medium
63.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,467
Total received (2018-2024)
Avg $495/year across 7 years
Top 47% in TX for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
128
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$366
2023
$739
2022
$448
2021
$422
2020
$455
2019
$611
2018
$427
Payments by company (2024)
ABBVIE INC.
$84
PROCEPT BioRobotics Corporation
$55
Axonics, Inc.
$48
Boston Scientific Corporation
$47
180 Medical, Inc.
$37
Janssen Biotech, Inc.
$20
Cook Medical LLC
$18
Ferring Pharmaceuticals Inc.
$17
UROGEN PHARMA, INC.
$14
PFIZER INC.
$13
Myriad Genetic Laboratories, Inc.
$13
Top 3 companies account for 51.1% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$757
Intuitive Surgical, Inc.
$482
PROCEPT BioRobotics Corporation
$460
Janssen Biotech, Inc.
$286
Boston Scientific Corporation
$208
AbbVie Inc.
$133
Endo Pharmaceuticals Inc.
$126
ABBVIE INC.
$125
AbbVie, Inc.
$125
Janssen Products, LP
$100
PFIZER INC.
$90
Axonics, Inc.
$80
Axonics Modulation Technologies, Inc.
$66
180 Medical, Inc.
$64
Teleflex LLC
$40
Cook Medical LLC
$36
Alexion Pharmaceuticals, Inc.
$25
Amgen Inc.
$22
UroGen Pharma, Inc.
$22
Myovant Sciences Inc.
$20
Travere Therapeutics, Inc.
$20
Coloplast Corp
$20
COLOPLAST CORP
$20
Ferring Pharmaceuticals Inc.
$17
Laborie Medical Technologies Corp.
$16
Medtronic USA, Inc.
$15
Hollister Incorporated
$15
BOSTON SCIENTIFIC CORPORATION
$14
Medtronic, Inc.
$14
UROGEN PHARMA, INC.
$14
Myriad Genetic Laboratories, Inc.
$13
NeoTract Inc.
$13
NxThera, Inc.
$10
Top 3 companies account for 49.0% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Androgel · Axonics · Axonics r-SNM System · BOTOX · Cook Medical Lasers · Da Vinci Surgical System · ERLEADA · EVENITY · Erleada · GENERAL - BPH · GENERAL BPH · GENERAL FEMALE SUI · GENTLECATH · GREENLIGHT · General - Therapies · INTERSTIM · JELMYTO · LITHOVUE · LUPRON DEPOT · Lupron · MYRBETRIQ · Myrbetriq · ORGOVYX · PROLARIS · RESONANCE · Restorelle · Rezum · Rezum Generator · SOLYX · SpeediCath · Thiola · ULTOMIRIS · UroLift · UroLift System · VaPro Pocket · Veozah · XIAFLEX · XTANDI · Xtandi · ZYTIGA · rezum Generator
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
6
County median income
$66,254
Nearest hospital to ZIP centroid (approximate)
RIVER CREST HOSP
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bradley is a clinical cardiology specialist, with above-average Medicare volume (top 17% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bradley experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Bradley performed 1,980 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Bradley receive payments from pharmaceutical companies?
Yes. Dr. Bradley received a total of $3,467 from 33 companies across 128 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bradley's costs compare to other urology physicians in San Angelo?
Dr. Bradley's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bradley) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in San Angelo
Browse urology physicians in San Angelo ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
By company
PROCEPT BioRobotics Corporation Payments to Doctors
See all physicians who received payments from PROCEPT BioRobotics Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology